Health
FDA to Review Safety Data for AstraZeneca COVID-19 Vaccine – Contagionlive.com
The agency requested data this week, following the pause of large-scale international assessment after a non-fatal serious adverse event was reported in a UK pa…
Scrutiny into the safety of the AstraZeneca and University of Oxford investigative coronavirus 2019 (COVID-19) vaccine candidate has not yet been eased.The US Food and Drug Administration (FDA) has started investigation into a serious adverse event reported by a UK-based volunteer participant in the phase 3 trial for adenovirus AZD1222, initially reported in the first week of September.
According to Reuters, the agency anticipates to receive requested safety data later this week, at which time …
-
Business23 hours agoWhy Amotiv, Breville, Life360, and Woodside shares are tumbling today
-
Noosa News21 hours agoDevastating update in search for missing Queensland mother Tayla Spies as police find human remains near her ute
-
Business20 hours agoOwn the world with these 3 global ASX ETFs
-
Noosa News24 hours agoQueensland police to be given powers to issue on-the-spot orders to domestic violence perpetrators